| Mr Leon Johnson, MED, LPC | |
|
4400 Buffalo Gap Rd, Ste 3400-c, Abilene, TX 79606-2723 | |
| (325) 668-0665 | |
| (325) 673-3310 |
| Full Name | Mr Leon Johnson |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 4400 Buffalo Gap Rd, Abilene, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770647083 | NPI | - | NPPES |
| 342444 | Other | TX | MANAGED HEALTH NETWORK |
| 6576LC | Other | TX | BLUECROSS BLUESHIELD |
| 1499873-01 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 17598 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Leon Johnson, MED, LPC 4780 Fm 603, Clyde, TX 79510-6148 Ph: (325) 668-0665 | Mr Leon Johnson, MED, LPC 4400 Buffalo Gap Rd, Ste 3400-c, Abilene, TX 79606-2723 Ph: (325) 668-0665 |
News Archive
The Milwaukee Journal Sentinel reports on insurers' wariness about how business will work on these new marketplaces, which are being set up as part of the federal health law.
A team of scientists from the United Kingdom has recently conducted a multicenter, prospective cohort study to investigate long-term consequences of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.
The health of the surrounding tissue affects the success of a dental implant. Identifying and reducing risk factors is therefore a key step in the implant process. Now a combination of genes has been identified as a possible indicator of greater tissue destruction leading to negative outcomes for implants.
› Verified 8 days ago
Ms. Nancy W Elliot, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2626 S Clack St, Abilene, TX 79606 Phone: 325-690-5131 Fax: 325-690-5228 | |
Thomas Louis Boyd, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 717 S Leggett Dr, Abilene, TX 79605 Phone: 325-695-2673 Fax: 325-793-1352 | |
Erika Yourdan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1317 Hickory St, Abilene, TX 79601 Phone: 325-232-7099 Fax: 325-788-0017 | |
Steven Ronald Rowlands, LMFT, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1925 Willow Dr, Abilene, TX 79602 Phone: 325-676-2309 | |
Rick A Sanders, M ED LPC LCDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 4601 Buffalo Gap Rd, Suite A1, Abilene, TX 79606 Phone: 325-692-1531 Fax: 325-701-9944 | |
Mrs. Heather Marie Jones, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 765 Orange St, Abilene, TX 79601 Phone: 325-670-4829 Fax: 325-670-4831 | |
Vizion Danette Jackson, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 697 Louisiana Rd, Abilene, TX 79607 Phone: 325-696-8378 |